Search results
Results from the WOW.Com Content Network
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey , [ 2 ] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol-Myers Squibb provides a higher 4.3% yield and an acquisition-driven strategy to counter its 2028 patent cliff. Merck offers a lower but still attractive 3.25% yield, with its specialty ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Bristol-Myers won't make any investor into a millionaire overnight. Its market cap is upwards of $118 billion, and in 2023 its top line was worth $45 billion, with net income of nearly $8 billion.
Bristol Myers Squibb (NYSE: BMY) has had a rough past five years. Its shares are barely in the green, its financial results have been unimpressive, and it has faced important patent cliffs. Most ...
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb_Company&oldid=971830359"
The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital (BMSCH) is a freestanding, 89-bed [1] pediatric acute care children's hospital adjacent to RWJUH. It is affiliated with both Robert Wood Johnson Medical School and the neighboring PSE&G Children's Specialized Hospital , and is one of three children's ...
Image source: The Motley Fool. Bristol Myers Squibb (NYSE: BMY) Q3 2024 Earnings Call Oct 31, 2024, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants